Cargando…

Predictive Value of Skeletal Muscle Mass in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients Treated With Immune Checkpoint Inhibitors

BACKGROUND: Reduced muscle mass has been associated with increased treatment complications in several tumor types. We evaluated the impact of skeletal muscle index (SMI) on prognosis and immune-related adverse events (IrAEs) in a cohort of recurrent/metastatic (R/M) head and neck squamous cell carci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arribas, Lorena, Plana, Maria, Taberna, Miren, Sospedra, Maria, Vilariño, Noelia, Oliva, Marc, Pallarés, Natalia, González Tampán, Ana Regina, Del Rio, Luis Miguel, Mesia, Ricard, Baracos, Vickie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267860/ https://www.ncbi.nlm.nih.gov/pubmed/34249760 http://dx.doi.org/10.3389/fonc.2021.699668

Ejemplares similares

Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Taberna, Miren, et al.
Publicado: (2019)

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
por: Oliva, M, et al.
Publicado: (2019)

Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy
por: Marín-Jiménez, Juan A., et al.
Publicado: (2022)

The Multidisciplinary Team (MDT) Approach and Quality of Care
por: Taberna, Miren, et al.
Publicado: (2020)

Ibero-American Expert Consensus on Squamous Cell Carcinoma of the Head and Neck Treatment in Patients Unable to Receive Cisplatin: Recommendations for Clinical Practice
por: Falco, Agustín, et al.
Publicado: (2021)

HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients’ survival
por: Taberna, Miren, et al.
Publicado: (2018)

Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial
por: Fernández-Mateos, Javier, et al.
Publicado: (2020)

Differentially expressed alternatively spliced genes in skeletal muscle from cancer patients with cachexia
por: Narasimhan, Ashok, et al.
Publicado: (2017)

Simvastatin Enhances the Effects of Radiotherapy and Cetuximab on a Cell Line (FaDu) Derived from a Squamous Cell Carcinoma of Head and Neck()
por: de Llobet, Lara I., et al.
Publicado: (2014)

Dentition, nutritional status and adequacy of dietary intake in treatment naïve head and neck cancer patients
por: Kubrak, Catherine, et al.
Publicado: (2020)

SEOM clinical guidelines for the treatment of head and neck cancer (2020)
por: Mesia, R., et al.
Publicado: (2021)

Pitfalls in defining and quantifying cachexia
por: Baracos, Vickie E.
Publicado: (2011)

Psoas as a sentinel muscle for sarcopenia: a flawed premise
por: Baracos, Vickie E.
Publicado: (2017)

Concurrent depletion of skeletal muscle, fat, and left ventricular mass in patients with cirrhosis of the liver
por: Kazemi‐Bajestani, Seyyed Mohammad Reza, et al.
Publicado: (2015)

Small RNAome profiling from human skeletal muscle: novel miRNAs and their targets associated with cancer cachexia
por: Narasimhan, Ashok, et al.
Publicado: (2017)

The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions
por: Guigay, Joël, et al.
Publicado: (2019)

Immune-Driven Pathogenesis of Neurotoxicity after Exposure of Cancer Patients to Immune Checkpoint Inhibitors
por: Vilariño, Noelia, et al.
Publicado: (2020)

The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients
por: Taberna, Miren, et al.
Publicado: (2018)

How can artificial intelligence optimize value-based contracting?
por: Poveda, Jose Luis, et al.
Publicado: (2022)

Altered cancer cell metabolism and cachexia: Calculating the energetic cost of cancer
por: Friesen, Douglas, et al.
Publicado: (2014)

Immune Checkpoints Pathways in Head and Neck Squamous Cell Carcinoma
por: Veigas, Florencia, et al.
Publicado: (2021)

Defining a Standard Set of Health Outcomes for Patients With Squamous Cell Carcinoma of the Head and Neck in Spain
por: Arrazubi, Virginia, et al.
Publicado: (2022)

Assessing the Performance of Clinical Natural Language Processing Systems: Development of an Evaluation Methodology
por: Canales, Lea, et al.
Publicado: (2021)

Skeletal Muscle Pathological Fat Infiltration (Myosteatosis) Is Associated with Higher Mortality in Patients with Cirrhosis
por: Ebadi, Maryam, et al.
Publicado: (2022)

Ectopic fat in liver and skeletal muscle is associated with shorter overall survival in patients with colorectal liver metastases
por: van Dijk, David P.J., et al.
Publicado: (2021)

Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy
por: Chu, Michael P., et al.
Publicado: (2015)

Skeletal muscle density is an independent predictor of diffuse large B‐cell lymphoma outcomes treated with rituximab‐based chemoimmunotherapy
por: Chu, Michael P., et al.
Publicado: (2016)

Modeling the energetic cost of cancer as a result of altered energy metabolism: implications for cachexia
por: Friesen, Douglas E., et al.
Publicado: (2015)

Home-based functional walking program for advanced cancer patients receiving palliative care: a case series
por: Lowe, Sonya S, et al.
Publicado: (2013)

Factors Associated with Oral Cancerous and Precancerous Lesions in an Underserved Community: A Cross-Sectional Study
por: Badri, Parvaneh, et al.
Publicado: (2022)

TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck
por: Rubió-Casadevall, Jordi, et al.
Publicado: (2023)

A giant desmoid neck tumor: a case report
por: Pallarés Martí, Beatriz, et al.
Publicado: (2020)

Associations of pre‐existing co‐morbidities with skeletal muscle mass and radiodensity in patients with non‐metastatic colorectal cancer
por: Xiao, Jingjie, et al.
Publicado: (2018)

Nutritional status and body composition in Covid-19 oncological inpatients
por: González-Tampán, A.R., et al.
Publicado: (2021)

Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population
por: Fernández-Mateos, Javier, et al.
Publicado: (2019)

In Reply
por: de la Torre-Vallejo, Martha, et al.
Publicado: (2016)

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
por: Qi, Xinmeng, et al.
Publicado: (2017)

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
por: Mei, Zi, et al.
Publicado: (2020)

Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma
por: Fernández-Mateos, Javier, et al.
Publicado: (2017)

Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series
por: Marco, Carla, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3egv3m9aqhh9h4bt8phr81ca10